United States · FDA National Drug Code directory
Gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-631_2b5aee3a-519c-0872-e063-6294a90a1bb9
- Product NDC
- 71610-631
- Form
- CAPSULE
- Composition / generic term
- Gabapentin
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160218
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE in 1 BOTTLE, PLASTIC (71610-631-53) · 71610-631-53
- 90 CAPSULE in 1 BOTTLE, PLASTIC (71610-631-60) · 71610-631-60
- 180 CAPSULE in 1 BOTTLE, PLASTIC (71610-631-80) · 71610-631-80
- 270 CAPSULE in 1 BOTTLE, PLASTIC (71610-631-92) · 71610-631-92
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →